Local Recurrence in the Neck and Survival After Thyroidectomy for Metastatic Renal Cell Carcinoma

被引:9
作者
Iesalnieks, Igors [1 ,2 ]
Machens, Andreas [3 ]
Bures, Claudia [4 ]
Krenz, Detlef [5 ]
Winter, Hauke [6 ]
Vorlaender, Christian [7 ]
Bareck, Evelyne [8 ]
Alesina, Pier F. [9 ,10 ]
Musholt, Thomas [11 ]
Steinmueller, Thomas [12 ]
Anthuber, Matthias [13 ]
Goretzki, Peter [14 ]
Trupka, Arnold [15 ]
Mayr, Max [16 ]
Weber, Theresia [17 ]
Schlitt, Hans J. [1 ]
Dralle, Henning [2 ]
Hermann, Michael [3 ]
Agha, Ayman [1 ,2 ]
机构
[1] Univ Regensburg, Dept Surg, D-93053 Regensburg, Germany
[2] Klinikum Bogenhausen Munich, Dept Surg, D-81925 Munich, Germany
[3] Univ Halle Saale, Dept Surg, Halle, Germany
[4] Krankenanstalt Rudolfstiftung Wien, Dept Surg, Vienna, Austria
[5] Klinikum Dritter Orden, Dept Surg, Munich, Germany
[6] LMU, Dept Surg, Klinikum Grosshadern, Munich, Germany
[7] Burgerhosp Frankfurt Main, Dept Endocrine Surg, Frankfurt, Germany
[8] Landesklinikum Wiener Neustadt, Dept Surg, Neustadt, Austria
[9] Kliniken Essen Mitte, Chirurg Klin, Essen, Germany
[10] Kliniken Essen Mitte, Zentrum Minimal Invas Chirurg, Essen, Germany
[11] Johannes Gutenberg Univ Mainz, Dept Surg, D-55122 Mainz, Germany
[12] DRK Kliniken Berlin Westend, Dept Surg, Berlin, Germany
[13] Zent Klinikum, Dept Gen Visceral & Transplantat Surg, Augsburg, Germany
[14] Lukaskrankenhaus Neuss, Dept Surg 1, Neuss, Germany
[15] Klinikum Starnberg, Dept Surg, Starnberg, Germany
[16] Krankenhaus Barmherzigen Bruder, Dept Surg, Regensburg, Germany
[17] Katholisches Klinikum Mainz, Dept Endocrine Surg, Mainz, Germany
关键词
PULMONARY RESECTION; PROGNOSTIC-FACTORS; PANCREAS; SURGERY; CANCER; TRIAL; GLAND;
D O I
10.1245/s10434-014-4266-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Most investigations of thyroidectomy for metastatic renal cell carcinoma (RCC) are case studies or small series. This study was conducted to determine the contribution of clinical and histopathologic variables to local recurrence in the neck and overall survival after thyroidectomy for RCC metastases. The medical records of 140 patients with thyroidectomy for metastatic RCC performed between 1979 and 2012 at 25 institutions in Germany and Austria were analyzed. The median interval between nephrectomy and thyroidectomy was 120 months. Concurrence of thyroid and pancreatic metastases was present in 23 % of the patients and concurrence of thyroid and adrenal metastases in 13 % of the patients. Clinical outcome data were available for 130 patients with a median follow-up period of 34 months. The 5-year overall survival rate was 46 %, and 28 % of patients developed a local neck recurrence at a median of 12 months after thyroidectomy. Multivariate analysis showed that invasion of adjacent cervical structures (hazard ratio [HR] 3.2; p = 0.001), patient age exceeding 70 years (HR 2.5; p = 0.004), and current or past evidence of metastases to nonendocrine organs (HR 2.4; p = 0.003) were independent determinants of inferior overall survival. Conversely, invasion of adjacent cervical structures (HR 12.1; p < 0.0001) and year of thyroidectomy (HR 5.7 before 2000; p < 0.0001) were shown to be independently associated with local recurrence in the neck by multivariate analysis. Although significant improvement of local disease control in patients with thyroid metastases of RCC has been achieved during the last decade, overall outcome continues to be poor for patients with locally invasive thyroid metastases.
引用
收藏
页码:1798 / 1805
页数:8
相关论文
共 16 条
[1]   Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients [J].
Antonelli, A ;
Cozzoli, A ;
Simeone, C ;
Zani, D ;
Zanotelli, T ;
Portesi, E ;
Cunico, SC .
BJU INTERNATIONAL, 2006, 97 (03) :505-508
[2]   Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial [J].
Escudier, Bernard ;
Eisen, Tim ;
Stadler, Walter M. ;
Szczylik, Cezary ;
Oudard, Stephane ;
Staehler, Michael ;
Negrier, Sylvie ;
Chevreau, Christine ;
Desai, Apurva A. ;
Rolland, Frederic ;
Demkow, Tomasz ;
Hutson, Thomas E. ;
Gore, Martin ;
Anderson, Sibyl ;
Hofilena, Gloria ;
Shan, Minghua ;
Pena, Carol ;
Lathia, Chetan ;
Bukowski, Ronald M. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (20) :3312-3318
[3]   Metastatic renal cell carcinoma to the thyroid gland [J].
Heffess, CS ;
Wenig, BM ;
Thompson, LD .
CANCER, 2002, 95 (09) :1869-1878
[4]   Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma [J].
Hofmann, HS ;
Neef, H ;
Krohe, K ;
Andreev, P ;
Silber, RE .
EUROPEAN UROLOGY, 2005, 48 (01) :77-82
[5]   Thyroid metastases of renal cell carcinoma:: Clinical course in 45 patients undergoing surgery. assessment of factors affecting patients' survival [J].
Iesalnieks, Igors ;
Winter, Hauke ;
Bareck, Evelyne ;
Sotiropoulos, Georgios C. ;
Goretzki, Peter E. ;
Klinkhammer-Schalke, Monika ;
Broeckner, Stefan ;
Trupka, Arnold ;
Anthuber, Matthias ;
Rupprecht, Holger ;
Raab, Maximilian ;
Meyer, Willibald ;
Reichmann, Florian ;
Kaestel, Manfred ;
Mayr, Max ;
Braun, Wolfgang ;
Schlitt, Hans J. ;
Agha, Ayman .
THYROID, 2008, 18 (06) :615-624
[6]   Resection of metastatic renal cell carcinoma [J].
Kavolius, JP ;
Mastorakos, DP ;
Pavlovich, C ;
Russo, P ;
Burt, ME ;
Brady, MS .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2261-2266
[7]   Outcome after thyroid surgery for metastasis from renal cell cancer [J].
Machens, Andreas ;
Dralle, Henning .
SURGERY, 2010, 147 (01) :65-71
[8]   Evaluation of a new prognostic score (Munich score) to predict long-term survival after resection of pulmonary renal cell carcinoma metastases [J].
Meimarakis, Georgios ;
Angele, Martin ;
Staehler, Michael ;
Clevert, Dirk-Andre ;
Crispin, Alexander ;
Ruettinger, Dominik ;
Loehe, Florian ;
Preissler, Gerhard ;
Hatz, Rudolf A. ;
Winter, Hauke .
AMERICAN JOURNAL OF SURGERY, 2011, 202 (02) :158-167
[9]   Renal-cell carcinoma [J].
Motzer, RJ ;
Bander, NH ;
Nanus, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (12) :865-875
[10]   Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma [J].
Motzer, Robert J. ;
Hutson, Thomas E. ;
Olsen, Mark R. ;
Hudes, Gary R. ;
Burke, John M. ;
Edenfield, William J. ;
Wilding, George ;
Agarwal, Neeraj ;
Thompson, John A. ;
Cella, David ;
Bello, Akintunde ;
Korytowsky, Beata ;
Yuan, Jinyu ;
Valota, Olga ;
Martell, Bridget ;
Hariharan, Subramanian ;
Figlin, Robert A. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (12) :1371-1377